{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:00:00Z","timestamp":1773720000545,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41574-019-0198-2","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:04:10Z","timestamp":1555506250000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A new strategy for vascular complications in young people with type 1 diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"name":"on behalf of the Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Loredana","family":"Marcovecchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Neil","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Daneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Andrew W.","family":"Neil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2566-9304","authenticated-orcid":false,"given":"David B.","family":"Dunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"198_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas \u2014 8th edition. Diabetes Atlas \n                    http:\/\/www.diabetesatlas.org\n                    \n                   (2017)."},{"key":"198_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis, E. J. et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012. N. Engl. J. Med. 376, 1419\u20131429 (2017).","journal-title":"N. Engl. J. Med."},{"key":"198_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson, C. C. et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989\u20132013: a multicentre prospective registration study. Diabetologia 62, 408\u2013417 (2019).","journal-title":"Diabetologia"},{"key":"198_CR4","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.2337\/db10-0862","volume":"59","author":"AM Secrest","year":"2010","unstructured":"Secrest, A. M. et al. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 59, 3216\u20133222 (2010).","journal-title":"Diabetes"},{"key":"198_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S2213-8587(18)30035-4","volume":"6","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad, P., Donaghue, K. C. & Maahs, D. M. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol. 6, 809\u2013820 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"198_CR6","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1210\/jc.2017-01922","volume":"102","author":"EJ Barrett","year":"2017","unstructured":"Barrett, E. J. et al. Diabetic microvascular disease: an Endocrine Society Scientific Statement. J. Clin. Endocrinol. Metab. 102, 4343\u20134410 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"198_CR7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00125-007-0824-8","volume":"50","author":"CC Patterson","year":"2007","unstructured":"Patterson, C. C. et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 50, 2439\u20132442 (2007).","journal-title":"Diabetologia"},{"key":"198_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone, S. J. et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010. JAMA 313, 37\u201344 (2015).","journal-title":"JAMA"},{"key":"198_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00125-016-3914-7","volume":"59","author":"D Petrie","year":"2016","unstructured":"Petrie, D. et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia 59, 1167\u20131176 (2016).","journal-title":"Diabetologia"},{"key":"198_CR10","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00125-015-3857-4","volume":"59","author":"L Huo","year":"2016","unstructured":"Huo, L. et al. Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study. Diabetologia 59, 1177\u20131185 (2016).","journal-title":"Diabetologia"},{"key":"198_CR11","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","volume":"391","author":"EW Gregg","year":"2018","unstructured":"Gregg, E. W. et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391, 2430\u20132440 (2018).","journal-title":"Lancet"},{"key":"198_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani, A. et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 392, 477\u2013486 (2018).","journal-title":"Lancet"},{"key":"198_CR13","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/S0140-6736(15)60971-0","volume":"385","author":"FJ Cameron","year":"2015","unstructured":"Cameron, F. J. & Wherrett, D. K. Care of diabetes in children and adolescents: controversies, changes, and consensus. Lancet 385, 2096\u20132106 (2015).","journal-title":"Lancet"},{"key":"198_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/pedi.12702","volume":"19","author":"FJ Cameron","year":"2018","unstructured":"Cameron, F. J. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes in adolescence. Pediatr. Diabetes 19, 250\u2013261 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1399-5448.2009.00510.x","volume":"10","author":"ML Marcovecchio","year":"2009","unstructured":"Marcovecchio, M. L., Tossavainen, P. H. & Dunger, D. B. Status and rationale of renoprotection studies in adolescents with type 1 diabetes. Pediatr. Diabetes 10, 347\u2013355 (2009).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2352-4642(18)30309-2","volume":"3","author":"KA Sauder","year":"2019","unstructured":"Sauder, K. A. et al. Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study. Lancet Child Adolesc. Health 3, 35\u201343 (2019).","journal-title":"Lancet Child Adolesc. Health"},{"key":"198_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes Control and Complications Trial Research group","year":"1993","unstructured":"Diabetes Control and Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977\u2013986 (1993).","journal-title":"N. Engl. J. Med."},{"key":"198_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ecl.2017.10.012","volume":"47","author":"S Subramanian","year":"2018","unstructured":"Subramanian, S. & Hirsch, I. B. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes mellitus. Endocrinol. Metab. Clin. North Am. 47, 65\u201379 (2018).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"198_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-3476(94)70190-3","volume":"125","author":"Diabetes Control and Complications Trial Research group","year":"1994","unstructured":"Diabetes Control and Complications Trial Research group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 125, 177\u2013188 (1994).","journal-title":"J. Pediatr."},{"key":"198_CR20","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.2337\/dc19-S013","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes \u2014 2019. Diabetes Care 42, S148\u2013S164 (2019).","journal-title":"Diabetes Care"},{"key":"198_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/pedi.12742","volume":"19","author":"KC Donaghue","year":"2018","unstructured":"Donaghue, K. C. et al. ISPAD Clinical Practice Consensus Guidelines 2018: microvascular and macrovascular complications in children and adolescents. Pediatr. Diabetes 19, 262\u2013274 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR22","unstructured":"National Institute for Health and Care Excellence. Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE \n                    https:\/\/www.nice.org.uk\/guidance\/ng18\n                    \n                   (2015)."},{"key":"198_CR23","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/j.jcjd.2017.10.036","volume":"42","author":"DK Wherrett","year":"2018","unstructured":"Wherrett, D. K. et al. Type 1 diabetes in children and adolescents. Can. J. Diabetes 42, S234\u2013S246 (2018).","journal-title":"Can. J. Diabetes"},{"key":"198_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41574-018-0044-y","volume":"14","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann, M. & Hovorka, R. Technology in the management of type 1 diabetes mellitus \u2014 current status and future prospects. Nat. Rev. Endocrinol. 14, 464\u2013475 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"198_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/dme.13588","volume":"35","author":"P Prahalad","year":"2018","unstructured":"Prahalad, P. et al. Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabet. Med. 35, 419\u2013429 (2018).","journal-title":"Diabet. Med."},{"key":"198_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(09)61998-X","volume":"375","author":"R Hovorka","year":"2010","unstructured":"Hovorka, R. et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 375, 743\u2013751 (2010).","journal-title":"Lancet"},{"key":"198_CR27","doi-asserted-by":"publisher","first-page":"k1310","DOI":"10.1136\/bmj.k1310","volume":"361","author":"E Bekiari","year":"2018","unstructured":"Bekiari, E. et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 361, k1310 (2018).","journal-title":"BMJ"},{"key":"198_CR28","unstructured":"National Paediatric Diabetes Audit & Royal College of Paediatrics and Child Health. National Paediatric Diabetes Audit 2016\u201317 \u2014 care processes and outcomes. RCPCH \n                    https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2018-07\/npda_annual_report_2016_-_2017_april_2018_final_updated_3.pdf\n                    \n                   (2018)."},{"key":"198_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5694\/mja16.00737","volume":"206","author":"H Phelan","year":"2017","unstructured":"Phelan, H. et al. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes. Med. J. Aust. 206, 121\u2013125 (2017).","journal-title":"Med. J. Aust."},{"key":"198_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078","volume":"38","author":"KM Miller","year":"2015","unstructured":"Miller, K. M. et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 38, 971\u2013978 (2015).","journal-title":"Diabetes Care"},{"key":"198_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/bmj.39478.378241.BE","volume":"336","author":"R Amin","year":"2008","unstructured":"Amin, R. et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 336, 697\u2013701 (2008).","journal-title":"BMJ"},{"key":"198_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1399-5448.2011.00762.x","volume":"12","author":"YH Cho","year":"2011","unstructured":"Cho, Y. H. et al. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006. Pediatr. Diabetes 12, 682\u2013689 (2011).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/dme.13299","volume":"34","author":"DB Dunger","year":"2017","unstructured":"Dunger, D. B. Banting Memorial Lecture 2016 Reducing lifetime risk of complications in adolescents with Type 1 diabetes. Diabet. Med. 34, 460\u2013466 (2017).","journal-title":"Diabet. Med."},{"key":"198_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2337\/dc09-2278","volume":"33","author":"K Hietala","year":"2010","unstructured":"Hietala, K. et al. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care 33, 1315\u20131319 (2010).","journal-title":"Diabetes Care"},{"key":"198_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","volume":"328","author":"P Hovind","year":"2004","unstructured":"Hovind, P. et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328, 1105 (2004).","journal-title":"BMJ"},{"key":"198_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/pedi.12112","volume":"15","author":"YH Cho","year":"2014","unstructured":"Cho, Y. H., Craig, M. E. & Donaghue, K. C. Puberty as an accelerator for diabetes complications. Pediatr. Diabetes 15, 18\u201326 (2014).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR37","doi-asserted-by":"publisher","first-page":"F589","DOI":"10.1152\/ajprenal.00368.2001","volume":"283","author":"PH Lane","year":"2002","unstructured":"Lane, P. H. Diabetic kidney disease: impact of puberty. Am. J. Physiol. Physiol. 283, F589\u2013F600 (2002).","journal-title":"Am. J. Physiol. Physiol."},{"key":"198_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2265.2005.02185.x","volume":"62","author":"R Amin","year":"2005","unstructured":"Amin, R. et al. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Clin. Endocrinol. 62, 137\u2013144 (2005).","journal-title":"Clin. Endocrinol."},{"key":"198_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jc.2009-1756","volume":"95","author":"KJ Nadeau","year":"2010","unstructured":"Nadeau, K. J. et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J. Clin. Endocrinol. Metab. 95, 513\u2013521 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"198_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/db14-0765","volume":"64","author":"M Cree-Green","year":"2015","unstructured":"Cree-Green, M. et al. Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance. Diabetes 64, 383\u2013392 (2015).","journal-title":"Diabetes"},{"key":"198_CR41","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2337\/dc14-1331","volume":"37","author":"P Bjornstad","year":"2014","unstructured":"Bjornstad, P. et al. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes. Diabetes Care 37, 3033\u20133039 (2014).","journal-title":"Diabetes Care"},{"key":"198_CR42","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1161\/CIRCULATIONAHA.118.035525","volume":"138","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad, P. et al. Metformin improves insulin sensitivity and vascular health in youth with type 1 diabetes mellitus. Circulation 138, 2895\u20132907 (2018).","journal-title":"Circulation"},{"key":"198_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1167\/iovs.14-15147","volume":"56","author":"P Benitez-Aguirre","year":"2015","unstructured":"Benitez-Aguirre, P. et al. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Invest. Ophthalmol. Vis. Sci. 56, 571\u2013577 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"198_CR44","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2337\/diacare.26.5.1456","volume":"26","author":"R Amin","year":"2003","unstructured":"Amin, R. et al. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 26, 1456\u20131461 (2003).","journal-title":"Diabetes Care"},{"key":"198_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000173737","volume":"71","author":"E Codner","year":"2009","unstructured":"Codner, E. & Cassorla, F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm. Res. Paediatr. 71, 12\u201321 (2009).","journal-title":"Horm. Res. Paediatr."},{"key":"198_CR46","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/dc18-0319","volume":"41","author":"T Costacou","year":"2018","unstructured":"Costacou, T. et al. Dietary patterns over time and microalbuminuria in youth and young adults with type 1 diabetes: the SEARCH Nutrition Ancillary Study. Diabetes Care 41, 1615\u20131622 (2018).","journal-title":"Diabetes Care"},{"key":"198_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2014.10.014","volume":"107","author":"H-H Parving","year":"2015","unstructured":"Parving, H.-H., Persson, F. & Rossing, P. Microalbuminuria: a parameter that has changed diabetes care. Diabetes Res. Clin. Pract. 107, 1\u20138 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"198_CR48","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti, G. C. et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1, 1430\u20131432 (1982).","journal-title":"Lancet"},{"key":"198_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00285287","volume":"32","author":"T Deckert","year":"1989","unstructured":"Deckert, T. et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32, 219\u2013226 (1989).","journal-title":"Diabetologia"},{"key":"198_CR50","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","volume":"313","author":"P Rossing","year":"1996","unstructured":"Rossing, P. et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313, 779\u2013784 (1996).","journal-title":"BMJ"},{"key":"198_CR51","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","volume":"53","author":"TJ Orchard","year":"2010","unstructured":"Orchard, T. J. et al. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53, 2312\u20132319 (2010).","journal-title":"Diabetologia"},{"key":"198_CR52","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/db08-1543","volume":"58","author":"P-H Groop","year":"2009","unstructured":"Groop, P.-H. et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58, 1651\u20131658 (2009).","journal-title":"Diabetes"},{"key":"198_CR53","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","volume":"380","author":"CS Fox","year":"2012","unstructured":"Fox, C. S. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380, 1662\u20131673 (2012).","journal-title":"Lancet"},{"key":"198_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita, K. et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 3, 514\u2013525 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"198_CR55","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1159\/000328015","volume":"119","author":"AH Abdelhafiz","year":"2011","unstructured":"Abdelhafiz, A. H., Ahmed, S. & El Nahas, M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp. Nephrol. 119, e6\u2013e10 (2011).","journal-title":"Nephron Exp. Nephrol."},{"key":"198_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20050025","volume":"109","author":"CG Schalkwijk","year":"2005","unstructured":"Schalkwijk, C. G. & Stehouwer, C. D. A. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. 109, 143\u2013159 (2005).","journal-title":"Clin. Sci."},{"key":"198_CR57","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2337\/diacare.23.12.1811","volume":"23","author":"CJ Schultz","year":"2000","unstructured":"Schultz, C. J. et al. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes. Diabetes Care 23, 1811\u20131815 (2000).","journal-title":"Diabetes Care"},{"key":"198_CR58","first-page":"131","volume":"24","author":"DB Dunger","year":"2007","unstructured":"Dunger, D. B. et al. Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet. Med. 24, 131\u2013136 (2007).","journal-title":"Med."},{"key":"198_CR59","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1464-5491.2009.02761.x","volume":"26","author":"ML Marcovecchio","year":"2009","unstructured":"Marcovecchio, M. L. et al. Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuria. Diabet. Med. 26, 815\u2013819 (2009).","journal-title":"Diabet. Med."},{"key":"198_CR60","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2337\/dc08-1641","volume":"32","author":"ML Marcovecchio","year":"2009","unstructured":"Marcovecchio, M. L. et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 32, 658\u2013663 (2009).","journal-title":"Diabetes Care"},{"key":"198_CR61","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00125-009-1327-6","volume":"52","author":"ML Marcovecchio","year":"2009","unstructured":"Marcovecchio, M. L. et al. Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 52, 1173\u20131181 (2009).","journal-title":"Diabetologia"},{"key":"198_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2431-9-79","volume":"9","author":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial Research Group","year":"2009","unstructured":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial Research Group. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT). BMC Pediatr. 9, 79 (2009).","journal-title":"BMC Pediatr."},{"key":"198_CR63","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1703518","volume":"377","author":"ML Marcovecchio","year":"2017","unstructured":"Marcovecchio, M. L. et al. ACE inhibitors and statins in adolescents with type 1 diabetes. N. Engl. J. Med. 377, 1733\u20131745 (2017).","journal-title":"N. Engl. J. Med."},{"key":"198_CR64","unstructured":"National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. 1.15 \u2014 Managing complications. NICE \n                    https:\/\/www.nice.org.uk\/guidance\/ng17\/chapter\/1-recommendations#managing-complications\n                    \n                   (2016)."},{"key":"198_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2337\/dc13-1634","volume":"37","author":"ML Marcovecchio","year":"2014","unstructured":"Marcovecchio, M. L. et al. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 37, 805\u2013813 (2014).","journal-title":"Diabetes Care"},{"key":"198_CR66","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00125-017-4538-2","volume":"61","author":"PZ Benitez-Aguirre","year":"2018","unstructured":"Benitez-Aguirre, P. Z. et al. The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes. Diabetologia 61, 968\u2013976 (2018).","journal-title":"Diabetologia"},{"key":"198_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc14-1931","volume":"38","author":"YH Cho","year":"2015","unstructured":"Cho, Y. H. et al. Cardiac autonomic dysfunction is associated with high-risk albumin-to-creatinine ratio in young adolescents with type 1 diabetes in AdDIT (Adolescent Type 1 Diabetes Cardio-Renal Interventional Trial). Diabetes Care 38, 676\u2013681 (2015).","journal-title":"Diabetes Care"},{"key":"198_CR68","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2337\/dc14-0700","volume":"37","author":"O Maftei","year":"2014","unstructured":"Maftei, O. et al. Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT). Diabetes Care 37, 3069\u20133075 (2014).","journal-title":"Diabetes Care"},{"key":"198_CR69","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2337\/dc18-1125","volume":"41","author":"ML Marcovecchio","year":"2018","unstructured":"Marcovecchio, M. L. et al. Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine ratio: the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT). Diabetes Care 41, 1963\u20131969 (2018).","journal-title":"Diabetes Care"},{"key":"198_CR70","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7326\/0003-4819-134-5-200103060-00009","volume":"134","author":"ACE Inhibitors in Diabetic Nephropathy Trialist Group","year":"2001","unstructured":"ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann. Intern. Med. 134, 370\u2013379 (2001).","journal-title":"Ann. Intern. Med."},{"key":"198_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.292.3.331","volume":"292","author":"A Wiegman","year":"2004","unstructured":"Wiegman, A. et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292, 331\u2013337 (2004).","journal-title":"JAMA"},{"key":"198_CR72","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2215\/CJN.02870316","volume":"11","author":"IH Boer de","year":"2016","unstructured":"de Boer, I. H. et al. Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT\/EDIC Study. Clin. J. Am. Soc. Nephrol. 11, 1969\u20131977 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"198_CR73","unstructured":"Rapoff, M. Adherence to Pediatric Medical Regimens (Kluwer Academic\/Plenum Publishers, 1999)."},{"issue":"Suppl. 27","key":"198_CR74","first-page":"98","volume":"19","author":"PZ Benitez-Aguirre","year":"2018","unstructured":"Benitez-Aguirre, P. Z. et al. Top tertile urinary albumin creatinine ratio (ACR) doubles the risk of 3-step progression of diabeticretinopathy: the adolescent type 1 diabetes cardio-renal intervention trial (AdDIT) [abstract P150]. Pediatr. Diabetes 19 (Suppl. 27), 98 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"198_CR75","first-page":"CD006401","volume":"7","author":"A Vuorio","year":"2017","unstructured":"Vuorio, A. et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst. Rev. 7, CD006401 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"198_CR76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s10157-018-1673-0","volume":"23","author":"S Kuriyama","year":"2018","unstructured":"Kuriyama, S. Protection of the kidney with sodium\u2013glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trials. Clin. Exp. Nephrol. 23, 304\u2013312 (2018).","journal-title":"Clin. Exp. Nephrol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0198-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:47:08Z","timestamp":1684619228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-019-0198-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1038\/s41574-019-0198-2","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"17 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}